NCT03848013View on ClinicalTrials.gov

Treatment of Melasma Using Q-switched Nd: YAG Laser and Fractional CO2 Laser Separately and in Combination

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

April 30, 2019

Study Completion Date

June 30, 2019

Conditions
Melasma
Interventions
DEVICE

Q switched Nd YAG laser

Laser device emitting Q switched Nd YAG aiming for skin toning

DEVICE

Fractional CO2 laser

Laser device emitting fractionated ablative laser aiming for skin resurfacing

Trial Locations (1)

Unknown

Cairo University Kasr Al Ainy Hospital Dermatology department, Cairo

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER

NCT03848013 - Treatment of Melasma Using Q-switched Nd: YAG Laser and Fractional CO2 Laser Separately and in Combination | Biotech Hunter | Biotech Hunter